205 related articles for article (PubMed ID: 27362875)
1. Resistance to levothyroxine in a bariatric surgery patient: an indication for liquid formulation?
Hommel C; Delgrange E
Acta Clin Belg; 2017 Feb; 72(1):72-75. PubMed ID: 27362875
[TBL] [Abstract][Full Text] [Related]
2. TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation.
Fallahi P; Ferrari SM; Camastra S; Politti U; Ruffilli I; Vita R; Navarra G; Benvenga S; Antonelli A
Obes Surg; 2017 Jan; 27(1):78-82. PubMed ID: 27272506
[TBL] [Abstract][Full Text] [Related]
3. Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update.
Fallahi P; Ferrari SM; Ruffilli I; Ragusa F; Biricotti M; Materazzi G; Miccoli P; Antonelli A
Expert Opin Drug Deliv; 2017 May; 14(5):647-655. PubMed ID: 27552635
[TBL] [Abstract][Full Text] [Related]
4. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
Fallahi P; Ferrari SM; Antonelli A
Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
[TBL] [Abstract][Full Text] [Related]
5. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.
Fallahi P; Ferrari SM; Antonelli A
Endocrine; 2016 Jun; 52(3):597-601. PubMed ID: 26721663
[TBL] [Abstract][Full Text] [Related]
6. [Hypothyroidism due to pseudo-malabsorption of levothyroxine--Case 12/2009].
Müssig K; Mörike K; Klein R; Sträter J; Georges G; Häring HU; Schnauder G
Dtsch Med Wochenschr; 2009 Dec; 134(49):2514. PubMed ID: 19941234
[TBL] [Abstract][Full Text] [Related]
7. Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.
Guglielmi R; Grimaldi F; Negro R; Frasoldati A; Misischi I; Graziano F; Cipri C; Guastamacchia E; Triggiani V; Papini E
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):235-240. PubMed ID: 29376496
[TBL] [Abstract][Full Text] [Related]
8. Pseudomalabsorption of levothyroxine: a case report.
Ogawa D; Otsuka F; Mimura U; Ueno A; Hashimoto H; Kishida M; Ogura T; Makino H
Endocr J; 2000 Feb; 47(1):45-50. PubMed ID: 10811292
[TBL] [Abstract][Full Text] [Related]
9. Levothyroxine dose adjustment in hypothyroid patients following gastric sleeve surgery.
Richou M; Gilly O; Taillard V; Paul De Brauwere D; Donici I; Guedj AM
Ann Endocrinol (Paris); 2020 Oct; 81(5):500-506. PubMed ID: 32445637
[TBL] [Abstract][Full Text] [Related]
10. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.
Fallahi P; Ferrari SM; Ruffilli I; Antonelli A
BMC Gastroenterol; 2016 Feb; 16():22. PubMed ID: 26965518
[TBL] [Abstract][Full Text] [Related]
11. The administration of L-thyroxine as soft gel capsule or liquid solution.
Vita R; Fallahi P; Antonelli A; Benvenga S
Expert Opin Drug Deliv; 2014 Jul; 11(7):1103-11. PubMed ID: 24896369
[TBL] [Abstract][Full Text] [Related]
12. Levothyroxine Dosing Following Bariatric Surgery.
Gadiraju S; Lee CJ; Cooper DS
Obes Surg; 2016 Oct; 26(10):2538-42. PubMed ID: 27475799
[TBL] [Abstract][Full Text] [Related]
13. L-T4 Therapy in Enteric Malabsorptive Disorders.
Fallahi P; Ferrari SM; Elia G; Ragusa F; Paparo SR; Antonelli A
Front Endocrinol (Lausanne); 2021; 12():626371. PubMed ID: 33708175
[TBL] [Abstract][Full Text] [Related]
14. Oral levothyroxine therapy postbariatric surgery: Biopharmaceutical aspects and clinical effects.
Azran C; Porat D; Fine-Shamir N; Hanhan N; Dahan A
Surg Obes Relat Dis; 2019 Feb; 15(2):333-341. PubMed ID: 30704913
[TBL] [Abstract][Full Text] [Related]
15. Levothyroxine absorption in health and disease, and new therapeutic perspectives.
Ianiro G; Mangiola F; Di Rienzo TA; Bibbò S; Franceschi F; Greco AV; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2014; 18(4):451-6. PubMed ID: 24610609
[TBL] [Abstract][Full Text] [Related]
16. Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose.
Ferrari SM; Patrizio A; Mazzi V; Ragusa F; Botrini C; Elia G; Balestri E; Barozzi E; Rugani L; Bracchitta F; Stoppini G; Frenzilli G; Baldini E; Virili C; Benvenga S; Fallahi P; Antonelli A
Front Endocrinol (Lausanne); 2024; 15():1386510. PubMed ID: 38665263
[TBL] [Abstract][Full Text] [Related]
17. Liquid and softgel levothyroxine use in clinical practice: state of the art.
Virili C; Trimboli P; Romanelli F; Centanni M
Endocrine; 2016 Oct; 54(1):3-14. PubMed ID: 27473098
[TBL] [Abstract][Full Text] [Related]
18. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors.
Vita R; Saraceno G; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4481-6. PubMed ID: 25259910
[TBL] [Abstract][Full Text] [Related]
19. More than one way to skin a thyroid. Managing pediatric hypothyroidism with weekly intramuscular levothyroxine.
Alba P; Mitre N; Feldt M
J Pediatr Endocrinol Metab; 2016 Jun; 29(6):745-8. PubMed ID: 26959536
[TBL] [Abstract][Full Text] [Related]
20. Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009-2015.
Ferrara R; Ientile V; Arcoraci V; Ferrajolo C; Piccinni C; Fontana A; Benvenga S; Trifirò G
Endocrine; 2017 Oct; 58(1):143-152. PubMed ID: 28155170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
